
    
      The primary objective is to determine the burden of RSV disease in outpatient settings among
      32 to 35 wGA infants in the USA who did not receive RSV prophylaxis, as measured by rate of
      RSV-associated outpatient lower respiratory tract illness (LRI) during the infants' first RSV
      season.
    
  